Brought to you by
ECR 2019 / C-0589
Comprehensive anatomical and functional imaging in patients with type I neurofibromatosis using simultaneous FDG-PET/MRI
Congress: ECR 2019
Poster No.: C-0589
Type: Scientific Exhibit
Keywords: Hybrid Imaging, Oncology, Paediatric, PET-MR, MR, MR-Diffusion/Perfusion, Molecular imaging, Staging, Neoplasia, Cancer
Authors: C. P. Reinert, M. Schuhmann, B. Bender, C. La Fougère, J. Schäfer, S. Gatidis; Tübingen/DE
DOI:10.26044/ecr2019/C-0589

References

 

1.         Yap, Y.S., et al., The NF1 gene revisited - from bench to bedside. Oncotarget, 2014. 5(15): p. 5873-92.

2.         Ferner, R.E., et al., Guidelines for the diagnosis and management of individuals with neurofibromatosis 1. J Med Genet, 2007. 44(2): p. 81-8.

3.         Ducatman, B.S., et al., Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer, 1986. 57(10): p. 2006-21.

4.         Evans, D.G., et al., Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet, 2002. 39(5): p. 311-4.

5.         Combemale, P., et al., Utility of 18F-FDG PET with a semi-quantitative index in the detection of sarcomatous transformation in patients with neurofibromatosis type 1. PLoS One, 2014. 9(2): p. e85954.

6.         Canavese, F. and J.I. Krajbich, Resection of plexiform neurofibromas in children with neurofibromatosis type 1. J Pediatr Orthop, 2011. 31(3): p. 303-11.

7.         Wu, J.S. and M.G. Hochman, Soft-Tissue Tumors and Tumorlike Lesions: A Systematic Imaging Approach. Radiology, 2009. 253(2): p. 297-316.

8.         Piscitelli, O., et al., Neurofibromatosis type 1 and cerebellar T2-hyperintensities: the relationship to cognitive functioning. Dev Med Child Neurol, 2012. 54(1): p. 49-51.

9.         Gayre, G.S., et al., Long-term visual outcome in patients with anterior visual pathway gliomas. Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society, 2001. 21(1): p. 1-7.

10.       Omuro, A. and L.M. DeAngelis, Glioblastoma and other malignant gliomas: A clinical review. JAMA, 2013. 310(17): p. 1842-1850.

11.       Broski, S.M., et al., Evaluation of 18F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors. Skeletal Radiology, 2016. 45(8): p. 1097-1105.

12.       Demehri, S., et al., Conventional and functional MR imaging of peripheral nerve sheath tumors: initial experience. AJNR Am J Neuroradiol, 2014. 35(8): p. 1615-20.

13.       Gatidis, S., et al., Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous (1)(8)F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to (1)(8)F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography. Invest Radiol, 2016. 51(1): p. 7-14.

14.       Lu-Emerson, C. and S.R. Plotkin, The Neurofibromatoses. Part 1: NF1. Rev Neurol Dis, 2009. 6(2): p. E47-53.

15.       Chawla, S.C., et al., Estimated cumulative radiation dose from PET/CT in children with malignancies: a 5-year retrospective review. Pediatr Radiol, 2010. 40(5): p. 681-6.

16.       Boellaard, R., et al., FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging, 2015. 42(2): p. 328-54.

17.       Schafer, J.F., et al., Simultaneous whole-body PET/MR imaging in comparison to PET/CT in pediatric oncology: initial results. Radiology, 2014. 273(1): p. 220-31.

18.       Radiation dose to patients from radiopharmaceuticals (addendum 2 to ICRP publication 53). Ann ICRP, 1998. 28(3): p. 1-126.

19.       Vanderhoek, M., S.B. Perlman, and R. Jeraj, Impact of the definition of peak standardized uptake value on quantification of treatment response. J Nucl Med, 2012. 53(1): p. 4-11.

20.       Neubauer, H., et al., Diagnostic Value of Diffusion-Weighted MRI for Tumor Characterization, Differentiation and Monitoring in Pediatric Patients with Neuroblastic Tumors. Rofo, 2017. 189(7): p. 640-650.

21.       Billiet, T., et al., Characterizing the microstructural basis of "unidentified bright objects" in neurofibromatosis type 1: A combined in vivo multicomponent T2 relaxation and multi-shell diffusion MRI analysis. Neuroimage Clin, 2014. 4: p. 649-58.

POSTER ACTIONS Add bookmark Contact presenter Send to a friend Download pdf
SHARE THIS POSTER
2 clicks for more privacy: On the first click the button will be activated and you can then share the poster with a second click.

This website uses cookies. Learn more